Adage Capital Partners’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Adage Capital Partners’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-625,000	Closed	-$14.9M	–	815
2019 Q4	$14.9M	Buy	625,000 +25,000	+4%	+$690K	0.04%	455
2019 Q3	$16.1M	Buy	600,000 +100,000	+20%	+$2.81M	0.04%	418
2019 Q2	$13.6M	Hold	500,000	–	–	0.03%	456
2019 Q1	$17.4M	Buy	500,000 +25,000	+5%	+$721K	0.04%	416
2018 Q4	$9.27M	Buy	+475,000	New	+$9.77M	0.03%	524
2017 Q3	–	Sell	-100,000	Closed	-$5.62M	–	775
2017 Q2	$5.62M	Buy	+100,000	New	+$4.01M	0.01%	621
2014 Q2	–	Sell	-182,685	Closed	-$4.73M	–	758
2014 Q1	$4.73M	Hold	182,685	–	–	0.01%	595
2013 Q4	$4.7M	Buy	+182,685	New	+$4.44M	0.01%	592

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Adage Capital Partners's PTLA Position: Q1 2020 in Review

Adage Capital Partners sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 625,000 shares — an estimated $14.9M sold.

Adage Capital Partners first reported a position in PTLA in Q4 2013 and held it in 8 quarters. The position peaked at $17.4M in Q1 2019. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

Adage Capital Partners reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Adage Capital Partners sold 625,000 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $14.9M.
Adage Capital Partners first reported a position in Portola Pharmaceuticals, Inc. in Q4 2013 and held it in 8 quarters.
Adage Capital Partners's Portola Pharmaceuticals, Inc. position peaked at $17.4M in Q1 2019.
187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Adage Capital Partners's 13F filing for Q1 2020, filed 15 May 2020.